Skip to content
SensDx logo — Fast Precise and Ultrasensitive Digital Diagnostics Tests

SensDx

Fast Precise and Ultrasensitive Digital Diagnostics Tests

Founded 2014 Poland Poland 10 employees Biotechnology, Health Care

General Information

Company Name SensDx
Founded Year 2014
Location Poland Poland
Employees 10
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with SensDx. To contact SensDx, visit sensdx.eu.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does SensDx compare?

A PDF of SensDx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting SensDx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About SensDx

SensDx is a Polish startup operating in the telemedicine sector, with a focus on creating digital diagnostic testing technologies for both people and animals. The company's innovative solution revolves around a simple tool based on a fast, ultra-sensitive diagnostic test, complemented by a mobile application for easy result interpretation. These test tools are housed in specially-designed devices named Mobi for individual patients and Pro for medical professionals. Founded in 2014, SensDx has set out to revolutionize global telemedicine by offering accurate, fast, and user-friendly tests for detecting specific illnesses. The company's mission is to provide precise test results and diagnostic support to add value for both doctors and patients, with the vision of advancing telemedicine in a significant way. The company's key focus areas are in the industries of Biotechnology and Health Care. As of now, there is no publicly disclosed information about last investment or investors. With its strong emphasis on innovation and addressing critical needs in telemedicine, SensDx presents an intriguing potential for investment within the burgeoning healthcare technology sector.

Business keywords: telemedicine, diagnostic testing, digital diagnostics, mobile application, home testing, ultrasensitive tests, disease identification, telehealth, medical innovation

No funding data available for SensDx yet.

SensDx Alternatives & Competitors

View All Alternatives
SensDx vs

Domus is developing affordable and accurate respiratory disease home testing for everyone, everywher...

Grant
5 employees
Biotechnology, Health Care
SensDx vs

We pioneer approaches for better patient care and empower physicians to champion patient health toda...

Private Equity
171 employees
Biotechnology, Health Care
SensDx vs

Improving quality of life for patients by providing antimicrobial stewardship in a cost-effective ma...

Seed
13 employees
Biotechnology, Health Care

FAQ About SensDx

Fast Precise and Ultrasensitive Digital Diagnostics Tests
SensDx was founded in 2014.
SensDx is headquartered in Poland.
SensDx operates in Biotechnology and Health Care. Its work centres on telemedicine, diagnostic testing, digital diagnostics and mobile application.
SensDx has approximately 10 employees.
Top alternatives and competitors to SensDx include Domus Diagnostics, Inc, Pathnostics - A Diagnostics Solutions Company, Microplate Dx Limited, Biotome Pty Ltd, MultiplexDX International. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SensDx and Domus Diagnostics, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for SensDx, https://bouncewatch.com/company/sensdx, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout